Presentation TCT 2013 Procedural Experience and Outcomes in the CoreValve US Extreme Risk Study Presenter: Michael Reardon October 29, 2013 REGISTER for free or LOG IN to view this content Aortic Valve Presentation TCT 2013 Up Next Presentation TCT 2013 TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis Presenter: Michael Haude October 29, 2013 More slides + Presentation TCT 2013 Which Patients with Degenerative Mitral Valve Disease Are Appropriate for a Transcatheter Approach? Presenter: Olaf Franzen October 29, 2013 Presentation TAVR vs. Surgery in Intermediate Risk Patients Presenter: Martin Leon October 29, 2013 We Recommend
Presentation TCT 2013 TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis Presenter: Michael Haude October 29, 2013
Presentation TCT 2013 Which Patients with Degenerative Mitral Valve Disease Are Appropriate for a Transcatheter Approach? Presenter: Olaf Franzen October 29, 2013